Oruka Therapeutics (ORKA) Change in Accured Expenses (2014 - 2026)
Oruka Therapeutics (ORKA) posted Change in Accured Expenses of $5.06 million for Q2 2026, compared with -$2.09 million a year earlier.
Powered by 
Analysis
Oruka Therapeutics (ORKA) Change in Accured Expenses (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Oruka Therapeutics was $10.77 million, up 320.2% year-over-year; for FY2025, it came in at $7.25 million, up 120.1% from FY2024.
- Annual Change in Accured Expenses shows a five-year compound annual growth rate of 60.2% (FY2020 to FY2025).
- In prior years, Oruka Therapeutics' Change in Accured Expenses was $3.29 million in FY2024, -$526,000 in FY2023, -$934,000 in FY2022 and $435,000 in FY2021 (-36.6%).
- The Q2 2026 figure stands as the highest quarterly Change in Accured Expenses in data going back to Q1 2014.
- According to Business Quant data, Change in Accured Expenses for the three prior quarters was -$1.3 million (Q1 2026), $2.21 million (Q4 2025) and $4.81 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Oruka Therapeutics | 5.31 Bn | 3.37 Bn | - | 5.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.06 Mn |
| Mar 31, 2026 | -1.30 Mn |
| Dec 31, 2025 | 2.21 Mn |
| Sep 30, 2025 | 4.81 Mn |
| Jun 30, 2025 | -2.09 Mn |
| Mar 31, 2025 | 2.32 Mn |
| Dec 31, 2024 | 1.64 Mn |
| Sep 30, 2024 | 689,000.00 |
| Jun 30, 2024 | 188,000.00 |
| Mar 31, 2024 | 773,000.00 |
| Dec 31, 2023 | -427,000.00 |
| Sep 30, 2023 | -608,000.00 |
| Jun 30, 2023 | 447,000.00 |
| Mar 31, 2023 | 62,000.00 |
| Dec 31, 2022 | -342,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 156,000.00 |
| Mar 31, 2022 | -757,000.00 |
| Dec 31, 2021 | -475,000.00 |
| Sep 30, 2021 | 1.52 Mn |
API Access
Oruka Therapeutics Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ORKA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "ORKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ORKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();